The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s migraine treatment market report forecasts the migraine treatment market size to grow to $4.16 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Migraine Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Migraine Treatment Market Size Forecast
The global migraine treatment market is expected to grow from $2.68 billion in 2022 to $2.93 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The migraine treatment market size is expected to grow to $4.16 billion in 2027 at a CAGR of 9.2%.

North America held the largest migraine treatment market share.

Key Migraine Treatment Market Driver ­– Increase In The Prevalence Of Migraine
For instance, in September 2020, according to Migraine.com, a US-based website that provides the accurate and relevant information about migraine, in 2021, around 1 billion people globally and 39 million people in the United States suffered from migraines. As a result, migraine is now the third-most prevalent disease worldwide. Therefore, the increasing prevalence of migraine is driving the growth of the migraine treatment market.

Request for A Sample Of The Global Migraine Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

Key Migraine Treatment Market Trend – Technological Innovations
Major companies operating in the market are introducing technological innovations to sustain their position in the market. For instance, in March 2021, Neurolief, an Israel-based company that develops proprietary digital therapeutics neuromodulation technology, launched “Brain Neuromodulation Technology,” used for migraine treatment. It is the first non-invasive neuromodulation system used to treat acute migraine at home.

Migraine Treatment Market Segment
1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute/Abortive Treatment, Preventive/Prophylactic Treatment, Non-Pharmacological Therapies, and Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Migraine Treatment Market Major Players and Strategies
Major players in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Allergan Plc, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome, AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Dr. Reddy’s Laboratories Limited, and Impel Pharmaceuticals Inc.

In May 2022, Pfizer Inc., a US-based biopharmaceutical company, acquired Biohaven Pharmaceutical Holding Company Ltd. for approximately $11.6 billion. This acquisition will help Pfizer build on its legacy by delivering medicines for patients suffering from migraines worldwide. Biohaven Pharmaceutical Holding Company Ltd. is a US-based company with a product portfolio for neuropsychiatric diseases and neurological disorders.

The Migraine Treatment Global Market Report 2023 covers regional data on migraine treatment market size, migraine treatment market trends and drivers, opportunities, strategies, and migraine treatment market competitor analysis. The countries covered in the migraine treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A migraine is a neurological condition with the most prominent symptom being a throbbing, pulsating headache on one side of the brain. The migraine treatment is used to treat a headache that often affects one side of the head and can be extremely painful, throbbing, or pulsating, by blocking the pathways in the brain that cause pain. With the help of migraine treatment, future attacks and migraine symptoms can be stopped.

View More Reports Related To The Migraine Treatment Market –
Pain Management Devices And Therapies Global Market Report 2023
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Brain Tumor Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: